- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 28, 2026 | 26.67M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 26.81M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 26.79M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $66.12M |
| Capex | Q1 2026 · Mar 31, 2025 | $202.89M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $139.63M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $109.07M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $39.18M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $19.72M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.63B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.58B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $2.36B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $2.31B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $328.5M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $265.38M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $499.39M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $434.56M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.56B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.48B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.86 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.86 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.86 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.86 |
| Net Income | Q1 2026 · Mar 31, 2026 | $49.87M |
| Net Income | Q1 2026 · Mar 31, 2025 | $49.81M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $66.81M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $70.17M |
| Revenue | Q1 2026 · Mar 31, 2026 | $806.23M |
| Revenue | Q1 2026 · Mar 31, 2025 | $787.58M |